EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the AKT‐P53 / CREB pathway with epicatechin for improved prognosis of traumatic brain injury

Ziheng Wang iD, Zhichao Lu, Yixun Chen, Chenxing Wang, Peipei Gong, Rui Jiang, Qianqian Liu

CNS Neuroscience & Therapeutics · 2024-02 · 30 (2)

DOI: 10.1111/cns.14364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.07.2023. Verfasst von Ziheng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Catechin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nantong Natural Science Foundation (JC12022063), National Natural Science Foundation of China (82271415), Postgraduate Reasearch & Practice Innovation Program of Jiangsu Province (KYCX22-3364).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of this study was to evaluate the effect of epicatechin, on neurological recovery and neuroinflammation after traumatic brain injury (TBI) to investigate its potential value in clinical practice.

Methods

TBI model was established in adult rats by CCI method. The effect of epicatechin was evaluated after intraperitoneal injection. Neurological recovery after TBI was assessed by Morris Water Maze, mNSS score, Rotarod test and Adhesive removal test. Protein and gene expression was assessed by Western blot, ELISA, PCR and immunofluorescence. Furthermore, the use of AKT pathway inhibitors blocked the therapeutic effects of epicatechin clarifying AKT‐P53/CREB as a potential pathway for the effects of epicatechin.

Results

Administering epicatechin after TBI prevented neuronal death, reduced neuroinflammation, and promoted neurological function restoration in TBI rats. Network pharmacology study suggested that epicatechin may exert its therapeutic benefits through the AKT‐P53/CREB pathway Conclusion These results indicate that epicatechin, a monomeric compound derived from tea polyphenols, possesses potent antioxidant and anti‐inflammatory properties after TBI. The mechanism may be related to the regulation of the AKT‐P53/CREB signal pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, TraumaticCatechinAnimalsRatsDisease Models, AnimalNeuroinflammatory DiseasesPrognosisProto-Oncogene Proteins c-aktTumor Suppressor Protein p53

Stichwörter der Autor:innen

epicatechininflammationmicroglianeurological functiontraumatic brain injury

Substanzen

CatechinProto-Oncogene Proteins c-aktTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Neurosurgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, China.
  • Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau, China.
  • Eye Institute, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.

ORCID-Profile: Ziheng Wang

Förderung

  • Nantong Natural Science Foundation (JC12022063)
  • National Natural Science Foundation of China (82271415)
  • Postgraduate Reasearch & Practice Innovation Program of Jiangsu Province (KYCX22-3364)

Zitieren

APA

Wang, Z., Lu, Z., Chen, Y., Wang, C., Gong, P., Jiang, R., & Liu, Q. (2024). Targeting the AKT‐P53 / CREB pathway with epicatechin for improved prognosis of traumatic brain injury. CNS Neuroscience & Therapeutics, 30(2). https://doi.org/10.1111/cns.14364

Vancouver

Wang Z, Lu Z, Chen Y, Wang C, Gong P, Jiang R, et al. Targeting the AKT‐P53 / CREB pathway with epicatechin for improved prognosis of traumatic brain injury. CNS Neuroscience & Therapeutics. 2024;30(2). doi:10.1111/cns.14364

BibTeX
@article{Wang2024,
  author = {Wang, Ziheng and Lu, Zhichao and Chen, Yixun and Wang, Chenxing and Gong, Peipei and Jiang, Rui and Liu, Qianqian},
  title = {Targeting the AKT‐P53 / CREB pathway with epicatechin for improved prognosis of traumatic brain injury},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {2},
  doi = {10.1111/cns.14364}
}
Kostenlos starten →